875 E. Wisconsin Ave,Suite 800
Milwaukee , WI, 53202

Rank

Rank Universe

Summary

The fund seeks maximum capital appreciation in the long term by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in US and non-US growth companies, including depositary receipts.

More

Link

Directors

Dec 14, 2023
  • Coleen Downs Dinneen
  • Gregory K. Ramirez
  • Peter M. Lebovitz
  • Peter E. Sundman
  • Gail L. Hanson
  • Bonnie L. Howard
  • William J. Kelly

Chief Compliance Officer

  • Jill M. Demski

Fund Manager(s)

  • James Hamel
  • Matthew Kamm
  • Jason White
  • Craigh Cepukenas
  • Jay Warner

Price

  • $ 36.88 ( +0.36 )
    Nov 1, 2024
    Last Close
  • Net Assets
  • $2.8B
    Feb 28, 2024
  • Holding
  • 47
    Aug 29, 2024
    More

  • 52-Week High/Low
  • $37.81 - $28.07
  • Turnover
  • 37.3%
  • Expense Ratio
  • 0.91%

Company Name

Holding

Novo Nordisk A/S 5.98 %
Boston Scientific Corp. 5.21 %
BlackRock Liquidity Funds Treasury Trust Fund - Institutional Class 4.32 %
Advanced Micro Devices, Inc. 4.25 %
Netflix, Inc. 3.95 %
Taiwan Semiconductor Manufacturing Co. Ltd. 3.81 %
Intuit, Inc. 3.4 %
Amazon.com, Inc. 3.2 %
Microsoft Corp. 3.14 %
London Stock Exchange Group plc 3.05 %
More 3.05 %

Documents

Prospectus

Annual Reports

Performance

YTD

8.1%

3 Year

-13.93%

5 Year

30.73%

Best

31.53%

2017

Worst

-30.19%

2022

Alpha

APHRX S&P 500

Chart +